Request Access to 
Genome-To-Treatment (GTRx™) is a first step in ending the therapeutic odyssey for rare genetic conditions.
GTRx is a virtual, automated system for frontline clinicians in intensive care settings that provides immediate management plans for critically ill infants and children with a new diagnosis of an identified rare genetic disease.GTRx is intended to provide immediate guidance to frontline neonatologists and intensivists to optimal therapies for critically ill infants and children in intensive care units as time is of the essence.
